Tag: oncology trial

New targeted therapy daraxonrasib improves survival in pancreatic cancer

byDeepti Shroff

May 5, 2026

1. Daraxonrasib significantly improves survival in metastatic pancreatic cancer compared with standard chemotherapy. 2. Strong response rates in combination therapy ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

New targeted therapy daraxonrasib improves survival in pancreatic cancer
Perianal lidocaine may improve comfort and efficiency during unsedated adult colonoscopy
Global medicine supply chains face mounting pressure amid Strait of Hormuz disruptions

No Result

View All Result